Photodynamic Therapy for Human Papilloma Virus-Related Diseases in Dermatology

Summary Although malignant and premalignant lesions are still the major targets, photodynamic therapy (PDT) may be used for eradicating non-malignant conditions such as human papillomavirus (HPV)-induced acanthomas of the skin and adjacent mucous membranes. HPV-induced skin lesions are very common and can present as foot and hand warts, planar warts and genital warts. Histologically these lesions display an acanthotic epidermis in a hyperproliferative state. The clinical course is characterized by high recurrence rates despite of surgical removal or application of cytotoxic agents. The variety of clinical treatment regimens demonstrates that no single treatment modality to date has been fully satisfactory and additional methods should be taken into consideration. HPV-induced skin lesions might provide a possible indication for topical PDT utilizing 5-aminolevulinic acid (ALA). The rapidly proliferating cells in viral acanthomas accumulate ALA-induced protoporphyrin IX selectively when compared to the surrounding non-infected cells. Also, more recently ALA-PDT has been shown to have antiviral properties and may be a new approach to destroy cells altered by virus infection by the interaction of absorbed light and the photosensitizer.

[1]  H. Hausen,et al.  Human Pathogenic Papillomaviruses , 1994, Current Topics in Microbiology and Immunology.

[2]  Martin Kriegmair,et al.  CELLULAR FLUORESCENCE OF THE ENDOGENOUS PHOTOSENSITIZER PROTOPORPHYRIN IX FOLLOWING EXPOSURE TO 5‐AMINOLEVULINIC ACID , 1995, Photochemistry and photobiology.

[3]  M. Landthaler,et al.  [Postoperative adjuvant therapy with interferon alfa-2B following laser surgery of condylomata acuminata]. , 1990, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[4]  N. Christensen,et al.  Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus , 1996, Journal of virology.

[5]  Z. Malik,et al.  Treatment of viral infections with 5‐aminolevulinic acid and light , 1997, Lasers in surgery and medicine.

[6]  K. Specht THE ROLE OF DNA DAMAGE IN PM2 VIRAL INACTIVATION BY METHYLENE BLUE PHOTOSENSITIZATION , 1994, Photochemistry and photobiology.

[7]  A. Ferenczy,et al.  Latent papillomavirus and recurring genital warts. , 1985, The New England journal of medicine.

[8]  R. G. Frank,et al.  Photodynamic therapy for condylomata acuminata with local application of 5-aminolevulinic acid. , 1996, Genitourinary medicine.

[9]  N. Kollias,et al.  Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5‐aminolaevulinic acid: implications for photodynamic treatment , 1997, The British journal of dermatology.

[10]  A. Ferenczy,et al.  Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. , 1998, Archives of dermatology.

[11]  L. Braathen,et al.  Topical photodynamic therapy in verrucae. A pilot study. , 1995, Dermatology.

[12]  J. Lenard,et al.  PHOTOINACTIVATION OF INFLUENZA VIRUS FUSION AND INFECTIVITY BY ROSE BENGAL , 1993, Photochemistry and photobiology.

[13]  C. Lytle,et al.  Photodynamic therapy for herpes simplex: a critical review. , 1979, Pharmacology & therapeutics.

[14]  A. Pardee,et al.  Photodynamic inactivation of free and vegatative bacteriophage T4. , 1967, Biochimica et biophysica acta.

[15]  S. Iinuma,et al.  A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. , 1994, British Journal of Cancer.

[16]  E. Ben-hur,et al.  Silicon Phthalocyanine Pc 4 and Red Light Causes Apoptosis in HIV‐infected Cells , 1997, Photochemistry and photobiology.

[17]  S. Spruance,et al.  Treatment of genital warts with an immune-response modifier (imiquimod). , 1998, Journal of the American Academy of Dermatology.

[18]  J C Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.

[19]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[20]  E. Villiers Human Pathogenic Papillomavirus Types: An Update , 1994 .

[21]  Christian Gluud,et al.  Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial , 2000, The Lancet.

[22]  M. Korbelik,et al.  Induction of tumor immunity by photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.

[23]  M W Berns,et al.  Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid. , 1996, American journal of obstetrics and gynecology.

[24]  A. Ferenczy Laser treatment of genital human papillomavirus infections in the male patient. , 1991, Obstetrics and gynecology clinics of North America.

[25]  B. Lambrecht,et al.  Photoinactivation of Viruses in Human Fresh Plasma by Phenothiazine Dyes in Combination with Visible Light , 1991, Vox sanguinis.

[26]  L. Koutsky Epidemiology of genital human papillomavirus infection. , 1997, The American journal of medicine.

[27]  W. Sluiter,et al.  Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. , 1997, Cancer research.

[28]  S. Jabłońska,et al.  Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. , 1995, Archives of dermatology.

[29]  B. Henderson,et al.  Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. , 1997, Cancer research.

[30]  I. Stender,et al.  Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5‐aminolaevulinic acid: a pilot study , 1999, Clinical and experimental dermatology.

[31]  B. Ortel,et al.  Photodynamic therapy and fluorescence diagnosis in dermatology , 2001 .

[32]  M. Lutzner,et al.  Interferon and retinoid treatment of warts. , 1985, Clinics in dermatology.

[33]  J. D. Christensen,et al.  Refractory condylomata acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treatment. , 1985, Genitourinary medicine.

[34]  W. Stolz,et al.  Epidermodysplasia verruciformis treated using topical 5‐aminolaevulinic acid photodynamic therapy , 1999, The British journal of dermatology.

[35]  A. Ferenczy,et al.  Therapeutic approaches to genital warts. , 1997, The American journal of medicine.